Main Subject - Internet and Businesses Online

There is a recent news item which has appeared about Google Adsense and caught my attention and I quote the same for your reference. <

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

blockquote>

Google AdSense Testing Cost-Per-Action Payments (Search Engine Journal) Google AdSense Testing Cost-Per-Action Pay

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ments Google AdSense is planning on testing publisher revenue payments on a Cost-Per-Action basis, and according to an email sent to Da

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

vid Jackson of the SeekingAlpha network, is inviting AdSense publishers to test the new revenue structure. David received this message

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

rom Google AdSense : The Google AdSense team would like to invite [...]
Google Launches Cost Per Action AdSense (Slashdot)

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

> rustybrick writes "Google has launched an invite only test of CPA (cost per action) AdSense ads. So instead of getting paid per clic

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

k or per impression, you now can get paid for an action, such as a sale or lead referral."

As you are aware online inte

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

rnet advertisements are generally of the following kinds

Cost Per Click (CPC) .
Cost Per Impressions (CPM)

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Cost Per Lead (CPL)

It is not completely a novel idea. The affiliate managers like Link Share, Commission Junction et

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

c. used to have Cost Per Lead advertisement as an effective alternative to CPM and CPC methods. Google adwords and adsense are using r

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ight now CPC and CPM methods only. CPM is ok when your ad is very generic and attractive to all people and the appeal is such that you

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

need not specially target or differentiate by means of keywords. High Click Through Rate (CTR) is expected for thousand impressions.

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

PC involves in charging the advertisers only if someone clicks the ad. This is preferable for most businesses and purposes to CPM in g

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

eneral.

Cost Per Lead if implemented, a higher Adsense revenue may be generated and expected from the point of publisher's view. For

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

example ebay.in pays roughly a dollar per lead for their affiliate programs or for introducing a lead who opens an account with them.

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

For advertiser also you need not pay simply for impressions or clicks and you need to pay only for confirmed leads so that there is opt

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

mization of advertisement costs visa vis revenue generated.

It will be a win win situation for both the publishers and the advertise

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

rs if Cost Per Lead or Cost Per Sale type of advertisements is introduced by Google for their AdSense or AdWords programs. However opp

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ortunities for those PPC players who are using the difference an advertiser client pays for a lead and the intermediate affiliate membe

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

r pays for impressions or clicks as a profit will be shut down if advertisers resort to complete Pay Per Lead or Pay Per Sale campaigns

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Main Subject - Google Adsense New Innovative Initiative: Pay Per Peformance - A Progressive and Proactive Step

Related Articles: